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bstract
Wild Panax ginseng C.A. Meyer (WG) is a well-known medicinal herb. In this study, the protective effects of a water extract from the root of
G on benzo[]pyrene (BP)-induced hepatotoxicity and the mechanism of these effects were investigated for the first time. The effects of WG
n liver toxicities induced by BP were assessed by blood biochemical and histopathological analyses. BP caused severe liver injury in rats, as
ndicated by elevated plasma ALT, AST and LPO levels. Pretreatment with WG for 4 weeks completely abrogated increases in the ALT, AST and
PO levels when challenged with BP. Reductions in GSH content and GST activity by BP were reversed by WG. These protective effects of WG
gainst BP-induced toxicity were consistent with the results of histopathological examinations. We next examined the effects of WG on the gene
xpression of the enzymes that metabolize BP in H4IIE cells. CYP1A1 mRNA and protein expression were increased by BP. WG moderately
nhibited BP-induced CYP1A1 gene expression. Moreover, GSTA2, GSTA3 and GSTM2 gene expressions were significantly increased by WG
hrough the Nrf2/antioxidant responsive element pathway for enzyme induction. In summary, WG is efficacious in protecting against BP-induced
epatotoxicity as results of metabolic regulations through both the inhibition of metabolic enzyme activation and the enhancement of electrophilic
etoxification, implying that WG should be considered a potential chemopreventive agent.
2007 Elsevier Ireland Ltd. All rights reserved.
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. IntroductionGinseng is a well-known medicinal herb in traditional Asian
edicine and is considered an adaptogen. Panax ginseng C.A.
eyer (Araliaceae), which grows in China and Korea, has
variety of beneficial biological actions that include anti-
Abbreviations: ARE, antioxidant response element; BP, benzo[]pyrene;
YP450 1A1, cytochrome P450 1A1; FCS, fetal calf serum; GST, glutathione
-transferase; MEM, minimal essential medium; NF-E2 related factor2, Nrf2;
BS, phosphate-buffered saline; SDS, sodium dodecylsulfate
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oi:10.1016/j.jep.2007.05.014arcinogenic, anti-diabetic and anti-inflammatory effects, as
ell as cardiovascular protection and neuroprotection (Zhang et
l., 1996; Yun et al., 2001a; Joo et al., 2005; Jung et al., 2005).
anax ginseng appears to inhibit some characteristics associ-
ted with cancer in animal models and human studies (Shin et
l., 2000). As cancer is quickly becoming the leading cause of
eath in the world, many reports have focused on chemopre-
ention trials with Panax ginseng. Most of the pharmacological
ctions of ginseng are attributed to a variety of ginsenosides,
hich are triterpenoid saponins (Attele et al., 1999; Huang et
l., 2005). The physiological and medicinal effects of the vari-
us ginsenosides differ and can even be oppositional (Sengupta
t al., 2004; Joo et al., 2005). Since ginsenosides produce effects
hat differ from one another, and a single ginsenoside initiates
ultiple actions, the overall pharmacology of ginseng is com-
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nal activity of a wide range of biological actions (Tsang et al.,
985; Nishino et al., 2001; McElhaney et al., 2004).
Wild ginseng is not cultivated domestically; rather, it grows
aturally and is harvested from wherever it is found growing.
t is considered superior to domestic ginseng, and it has been
hown to contain higher levels of ginsenoside (Betz et al., 1984;
oster, 2005), although Lui and Staba (1980) reported minimal
ifferences in total ginsenoside content between wild and culti-
ated ginseng. Ginsenoside levels were consistently lower from
he more intensively cultivated garden locations, but growth was
onsistently higher (Lim et al., 2005). It is widely accepted in
oth Korea and China that wild ginseng is more active than cul-
ivated ginseng in chemoprevention. However, little has actually
een reported on the effectiveness of wild ginseng.
Chemical carcinogenesis is caused by exposure to environ-
ental pollutants known as polycyclic aromatic hydrocarbons
PAH) (Varanasi et al., 1989; Topinka et al., 1998). Exposure
o PAH increases the risk of cancer in multiple organ sites. The
arcinogenicity of PAH requires metabolic activation to gen-
rate electrophilic intermediates that covalently bind to critical
NA targets to initiate carcinogenesis (Topinka et al., 1998).
enzo[]pyrene (BP), a prototypic PAH, is one of the most
otent carcinogens found in cigarette smoke, charred foods and
etroleum byproducts.
Oxidation and conjugation are two of the main reactions
nvolved in the biotransformation of xenobiotics. Cytochrome
450s (CYP450s) constitute the primary phase I enzyme system
esponsible for the oxidative metabolism of a variety of xeno-
iotics, including carcinogens and drugs (Huang et al., 1999).
he major activation pathway for the PAH is mediated by the
YP1A1 class of CYP450s, ultimately leading to the highly
utagenic BP diol epoxide (BPDE); this compound is believed
o be the ultimate carcinogenic metabolite of BP (Alexandrov
t al., 2002). The reactive metabolite generated by this pathway
ay subsequently be involved in additional metabolic processes
ith phase II detoxifying enzymes and may be converted to
nactive product.
For phase II detoxification reactions, glutathione S-
ransferase (GST), epoxide hydrolase and quinone reductase
re among the key enzymes involved. Since BPDE is a poor
ubstrate for epoxide hydrolase, the most important mecha-
ism of BPDE inactivation seems to be its conjugation with
SH, a reaction catalyzed by GSTs (EC 2.5.1.18) (Singh et
l., 2004). In the presence of GSH, cytosolic liver GST isoen-
ymes reduce the binding of anti-BPDE to nuclear DNA (Hesse
t al., 1980), which suggests that GSTs play a major role in
he detoxification of anti-BPDE. GSTs belong to a superfamily
f multifunctional isoenzymes that is divided into four major
lasses: , , , and . BPDEs are detoxified predominantly
y GSTs; the  class exhibits the highest activity towards most
PDEs, followed by GST and GST (Sundberg et al., 2002).
ntioxidant response elements (ARE) that are found in the reg-
latory regions of these genes control the transcription of these
nzymes. The transcription factor Nrf2, which binds to the ARE,
ppears to be essential for the induction of phase II enzymes,
ncluding GSTs (Ramos-Gomez et al., 2001). Nrf2-deficient
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inogens, including BP, through alterations in the expression
f detoxifying enzymes. The activity of many chemoprotective
gents, including oltipraz (Ramos-Gomez et al., 2003; Yu and
ensler, 2005), terpenoids, and isothiocyanate (McWalter et al.,
004), is also mediated by Nrf2-regulated gene activity against
arcinogens.
The main objective of this study was to evaluate the protective
ffects of WG from Sobaeksan on BP-induced hepatotoxicity,
s well as possible mechanisms for that protection. Here we
eport that the WG potently protects against BP-induced hepa-
otoxicity. This hepatoprotection by WG is regulated in part by
nhibition of CYP1A1 and by induction of GST /. In addition,
e demonstrated for the first time the importance of Nrf2/ARE
ignaling in WG-mediated GST induction, which is regulated at
he transcriptional level. These results suggest that WG should
e considered a potential chemopreventive.
. Materials and methods
.1. Reagents
Anti-CYP1A1 antibody was acquired from Oxford Biomed-
cal Research, Inc. (Oxford, MI). Anti-GST and anti-GST
ntibodies were purchased from Detroit R&D (Detroit, MI).
nti-Nrf2 antibody was obtained from Santa Cruz Biotech-
ology (Santa Cruz, CA). Horseradish peroxidase-conjugated
oat anti-rabbit and rabbit anti-goat IgGs were purchased from
ymed Laboratories (San Francisco, CA). Benzo[]pyrene (BP)
nd other reagents in the molecular studies were acquired from
igma Chemical (St. Louis, MO).
.2. Preparation of wild ginseng (WG) extract
Roots of WG (Panax ginseng C.A. Meyer) growing naturally
n forested areas (Sobaeksan, Korea) were collected and identi-
ed by the Sanha Sansam Research Center (Yongju, Korea).
he water extract was prepared by mixing 130 g WG with
000 ml of pure distilled water and extracting under reflux for
h by repeatedly heating the formula to 100 ◦C three times.
he extract was then filtered with filter paper (Advantec No.
, Japan), and the filtrate was concentrated to approximately
00 ml using a rotary evaporator (Heidolph WB 2000, Germany)
t −70 ◦C under vacuum and then freeze-dried. The yield of dry
atter from the extract was approximately 12.2%. Finally, the
xtract was dissolved in distilled water for oral administration
o Sprague–Dawley (SD) rats.
.3. Animals
Animal studies were conducted in accordance with institu-
ional guidelines for the care and use of laboratory animals.
even-week-old SD rats (160–180 g) were acquired from Ori-
nt Co. (Seoul, Korea), acclimatized for 1 week and maintained
n a clean chamber. The animals were fed a standard rat diet
Purina Korea, Seoul, Korea) and water ad libitum, and were
ept under pathogen-free conditions at a room temperature of
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as administered orally at a dose of 50 mg/kg/day to rats for
weeks through a gastric tube. Distilled water was adminis-
ered to control animals using the same feeding method over
he same period. After the final administration of WG, a single
ose of BP was injected intraperitoneally (0.5 mg/kg dissolved
n 100% corn oil). The animals were subsequently starved
vernight prior to sacrifice in order to reduce variations in hep-
tic metabolism. Blood samples were drawn directly from the
eart under ether anesthesia. The livers were removed immedi-
tely after perfusing the organs via injection of ice-cold saline
olution.
.4. Determination of AST and ALT activities
Aspartate aminotransferase (AST) and alanine aminotrans-
erase (ALT) activities in plasma were assayed with the ALT
nd AST kit (YD Diagnostics, Korea) following manufacturer’s
irection.
.5. Determination of LPO levels
Lipid peroxide (LPO) was determined by the colorimet-
ic thiobarbituric acid method (Buege and Aust, 1978). The
oncentration of lipid peroxides was calculated using a molar
bsorption coefficient of (1.56 × 105) M−1 cm−1 for malonalde-
yde, a product of lipid peroxidation.
.6. Determination of GSH levels
The glutathione (GSH) content was analyzed by the modified
llman’s method (Davies et al., 1984). The reaction mixture
onsisted of tissue lysate, 10 mM 5-5′-dithiobis-2-nitrobenzoic
cid (DTNB) and 0.02 M EDTA–Na2 in 0.4 M Tris–HCl buffer
pH 8.9). The reaction was initiated with 25 l of DTNB, and
onjugation of DTNB with GSH was monitored at 412 nm.
.7. Determination of GST activity
The total activity of GST in the liver homogenate was deter-
ined by the glutathione S-transferase (GST) assay kit (Cayman
hemical, USA) measuring the conjugation of 1-chloro-2,4-
initrobenzene (CDNB) with reduced glutathione.
.8. Histopathology
Hepatic morphology was assessed by light microscopy. The
eft lateral lobe of the liver was sliced (three slices per rat),
nd tissue slices were fixed in 10% buffered-neutral formalin
or 24 h. Fixed liver tissue slices were processed and embedded
n a paraplast automatic tissue processor, Citadel 2000 (Shan-
on Scientific, Cheshire, UK). Sections 5 m in thickness were
tained with hematoxylin and eosin before examination. A certi-
ed pathologist scored samples in a blinded fashion. An arbitrary
core was given to each microscopic field viewed at a magnifi-
ation of 200×. A minimum of five fields were scored per liver
lice to obtain the mean value.
2
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.9. Immunohistochemistry of CYP1A1
Immunohistochemical analysis for CYP1A1 was performed
sing the specific anti-CYP1A1 antibody. We used a commer-
ially available indirect avidin–biotin-complex kit (Vector Lab,
A, USA) for this analysis. In brief, tissue sections on slides
ere deparaffinized, hydrated at room temperature, incubated
ith proteinase K (20 g/ml) and blocked with serum (10%
ormal goat serum). Sections were then incubated with the spe-
ific antibody for 7 days at room temperature in a humidified
hamber. Slides were washed with phosphate-buffered saline
PBS) containing 0.1% Tween-20 following this incubation
eriod with the antibody. Sections were then incubated with
iotinylated goat anti-rabbit antibody for 5 days at 37 ◦C, fol-
owed by streptavidin–alkaline peroxidase complex for 1 h at
7 ◦C. Slides were washed with PBS 3–5 times after each incu-
ation. Finally, samples on slides were incubated with 0.05%
,3′-diaminobenzidine and 0.01% HCl in 0.05% Tris–HCl (pH
.4) as substrates for the phosphatase reaction until adequate
olor was developed. In some experiments, the sections were
ounterstained with hematoxylin.
.10. Cell culture
H4IIE cells (ATCC® CRL-1548), a rat hepatocyte-derived
ell line, were obtained from American Type Culture Collection
Rockville, MD, USA) and maintained in Dulbecco’s modi-
ed Eagle’s medium containing 10% fetal calf serum (FCS),
0 units/ml penicillin, and 50 g/ml streptomycin at 37 ◦C in a
umidified atmosphere with 5% CO2.
.11. Immunoblot analysis
Cells were incubated with WG (0.1–1 mg/ml) in the presence
r absence of 1 M BP for the indicated period. After washing
he cells twice with PBS, the cells were scraped and sonicated for
isruption. Protein samples containing microsomal or cytoso-
ic fractions were prepared by centrifugation at 10,000 × g for
0 min. The samples were stored at −70 ◦C until use. Sodium
odecylsulfate (SDS)–polyacrylamide gel electrophoresis and
mmunoblot analyses were performed according to published
rocedures (Cho et al., 2004). Microsomal and cytosolic pro-
eins were separated by 7.5% and 12% gel electrophoresis,
espectively, and transferred electrophoretically to nitrocellu-
ose membranes. The nitrocellulose membranes were incubated
ith the respective specific antibodies, followed by incubation
ith horseradish peroxidase-conjugated secondary antibody,
nd developed using the ECL® chemiluminescence detection
it (Amersham Biosciences, Amersham, UK). Equal loading
f proteins was verified by actin immunoblotting. Changes in
he levels of protein were determined via scanning densitom-
try. At least three separate experiments were performed with
ndependent lysates to confirm changes in the protein levels..12. RT-PCR
Total RNA was isolated from cells with TRIzol (Invitrogen).
everse transcription-polymerase chain reaction amplification

















































Effect of WG on serum AST and ALT activities in BP-treated rats
Group Karmen unit/ml of serum
AST ALT
Control 29.4 ± 2.0 35.4 ± 5.7
BP 377.4 ± 5.1** 440.5 ± 9.3**
WG + BP 55.4 ± 0.4## 55.4 ± 0.9##
WG 25.4 ± 0.4 29.5 ± 0.1
Rats were orally pretreated with WG at 50 mg/kg for 4 weeks with or without BP
treatment (0.5 mg/kg, i.p.), and the AST and ALT activities were monitored in the





















in levels that were 196% of BP-treated rats; however, treatment
with WG alone resulted in no change in GSH levels.
We next evaluated GST activity to determine the capacity
for GSH conjugation. BP treatment significantly decreased total
Table 2








Control 22.7 ± 1.6 50.3 ± 0.1 380.1 ± 6.6
BP 310.2 ± 2.9** 21.6 ± 2.4** 184.7 ± 8.1**
WG + BP 41.3 ± 4.2## 42.3 ± 0.0## 306.1 ± 0.2##
WG 11.9 ± 0.8 48.1 ± 0.2 344.4 ± 3.2S.I. Gum et al. / Journal of Ethn
as conducted as described by Cho et al. (2004). The number of
mplification cycles was empirically determined for each primer
air to identify the logarithmic phase. The specific primer sets
or CYP1A1 and GST genes including GSTA2, GSTA3, GSTA5,
STM1 and GSTM2 were designed to have a Tm of approx-
mately 55 ◦C and a GC content of ∼50%; BLAST searches
ere used to confirm the specificity of the selected nucleotide
equences. Band intensities of the amplified DNAs were com-
ared after visualization on an UV transilluminator.
.13. Construction of GSTA2 promoter-luciferase
onstructs and luciferase assay
Firefly luciferase reporter gene constructs, pGL-1651 and
GL-ARE, were generated as previously described (Kang
t al., 2003). To determine the promoter activity, we used a
ual-luciferase reporter assay system (Promega). Briefly, cells
7 × 105 cells/well) were replated in six-well plates overnight,
erum-starved for 6 h, and transiently transfected with one
f the GSTA2 promoter-luciferase constructs and the pRL-
V plasmid (Renilla luciferase expression for normalization)
sing Lipofectamine® reagent for 3 h (Life Technologies,
aithersburg, MD). Transfected cells were incubated in medium
ontaining 1% FCS for 3 h, and then exposed to WG (1 mg/ml)
or 18 h. Firefly and Renilla luciferase activities in cell lysates
ere measured using a luminometer (Luminoskan®, Thermo
absystems, Helsinki, Finland). The relative luciferase activity
as calculated by normalizing GSTA2 promoter-driven firefly
uciferase activity to that of Renilla luciferase.
.14. Statistical analysis
Scanning densitometry of the immunoblots was performed
ith Image Scan & Analysis System (Alpha-Innotech Corpora-
ion, San Leandro, CA). The area of each lane was integrated
sing AlphaEaseTM Version 5.5 software, followed by back-
round subtraction. One-way analysis of variance (ANOVA)
rocedures were used to assess significant differences among
reatment groups. For each significant effect of treatment, the
ewman–Keuls test was used for comparisons of multiple
roup means. The criteria for statistical significance were set
t P < 0.01. All statistical tests were two-sided.
. Results
.1. Effect of WG on BP-induced plasma AST and ALT
ctivities
We evaluated the effect of WG on BP-induced liver injury.
he degree of parenchymal cell injury and loss of hepatic func-
ion were analyzed by examining conventional serum enzymes,
ncluding AST and ALT. A single dose of BP caused severe liver
njury in rats, as indicated by significantly elevated plasma ALT
nd AST levels at 24 h (Table 1). Pretreatment of rats with WG
t 50 mg/kg for 4 weeks completely abrogated increases in ALT
nd AST activities following challenge with BP by 85% and






rom five rats. Paired Student’s t-test was used to compare the means of two
roups (significantly different from control, **P < 0.01; significantly different
rom BP, ##P < 0.01).
esults indicate that WG was efficacious in blocking increases in
lasma AST and ALT evoked by carcinogen-induced injuries.
.2. Suppression in lipid peroxidation by WG
Lipid peroxidation results in the formation of highly reactive
nd unstable hydroperoxides of both saturated and unsaturated
ipids. LPO levels were measured directly by utilizing the redox
eactions of the hydroperoxides with ferrous ions. The plasma
PO content, an index of the severity of liver cell damage, was
ignificantly elevated by a single intraperitoneal injection of BP
n rats (Table 2). Pretreatment with WG markedly decreased the
lasma LPO content in rats challenged by BP. The data indicate
hat WG had protective effects against BP-induced oxidative
njury.
.3. Effect of WG on GSH content and GST activity
In this study, intracellular GSH levels were measured. The
epatic GSH level was decreased to 21.6 mol/g tissue after
reatment with BP (Table 2). Thus, BP caused a 57% reduction
n hepatic GSH levels relative to control. The hepatic GSH level
as recovered by WG treatment for 4 weeks in rats, resultingats were treated as described in Table 1. The LPO or GST content and GST
ctivities were monitored in the plasma of rats 24 h after BP administration.
he values represent the mean ± S.D. from five rats. Paired Student’s t-test was
sed to compare the means of two groups (significantly different from control,
*P < 0.01; significantly different from BP, ##P < 0.01).


























Morphological activity index scores in the livers of BP treated rats with or
without WG
Parameters Control BP WG + BP WG
Necrosis 0 ++++ ++ 0
Degeneration 0 ++++ ++ 0
Hepatitis 0 ++ + 0
Rats were treated as described in Table 1. The liver morphology was assessed
microscopically 24 h after the last treatment. Living hepatocytes were defined as
the cells with well demarcated nuclear membranes and with prominent, round
central nucleoli after hematoxylin and eosin staining. Severity of liver lesions
was classified as follows, based on the extent of cytoplasmic necrosis and degen-
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ST activity in the cytosol compared to control (Table 2). The
ecrease in the cytosolic GST activity by BP was abolished by
retreatment with WG for 4 weeks. WG alone had no effects.
aken together, these results imply WG is efficacious in detox-
fying BP-induced metabolic reactive intermediates.
.4. Effects of WG on histopathology
In subsequent experiments, the effects of WG on the acute
iver toxicities induced by BP were assessed by histopatholog-
cal examinations. Healthy control rats showed no pathological
hanges (Fig. 1A). WG treatment alone also resulted in no
hange in hepatic morphology (Fig. 1B). In contrast, treatment
f rats with BP resulted in focal nodular necrosis and degener-
tion around the central veins and infiltration of inflammatory
ells in the periportal area (Fig. 1C). However, rats that had
een pretreated daily with WG at 50 mg/kg for 4 weeks exhibited
arked improvements in the liver histopathology induced by BP
Fig. 1D). Multiple analyses showed that WG weakened central
ecrosis and hepatocyte degeneration induced by BP from severe
o moderate (Table 3).
.5. Immunohistochemistry of CYP1A1
Carcinogens are detoxified via activation or inactivation of
epatic enzymes. BP is primarily bioactivated by the catal-
sis of CYP1A1 (Huang et al., 1999). Furthermore, BP can
nduce expression of CYP1A1 via the aryl hydrocarbon receptor
Houser et al., 1992; Huang et al., 1999). We immunohistochem-
cally examined the extent of CYP1A1 expression in rat liver
g
e
ig. 1. Representative hepatic histopathology (100×): the liver sections from control
lone (C); or WG (50 mg/kg/day, 4 weeks) + BP (0.5 mg/kg) (D) were stained with hem
entral vein (c); portal triad (p); severe necrosis (black arrow); degeneration of hepa
ere indicated.5–50%; severe (+++), 50–75%; and extensive (++++), 75% or more. Multi-
le analyses of four independent samples yielded reproducible and comparable
ata.
fter 4 weeks of WG treatment with or without BP. Healthy
ontrol and WG alone-treated rats showed no immunohisto-
hemical changes (Fig. 2A and B). However, exposure of rats to
P resulted in notable changes in CYP1A1 expression (Fig. 2C).
he intensities of CYP1A1 were weakly positive in rats treated
ith WG + BP compared to those treated by BP alone (Fig. 2D),
mplying that WG might decrease direct BPDE–DNA adduct
evels by BP.
.6. Effect of WG on CYP1A1 gene expressionNext, we evaluated effects of WG on BP-induced CYP1A1
ene expression in an in vitro cell culture model. CYP1A1 lev-
ls were monitored in H4IIE cells, a hepatocyte derived cell
rats (A); or rats treated with WG (50 mg/kg/day, 4 weeks) (B); BP (0.5 mg/kg)
atoxylin and eosin. Photomicrographs show various views of the liver sections:
tocytes (open arrow); disappearance of hepatic plate (*) and hepatitis (arrow)
S.I. Gum et al. / Journal of Ethnopharmacology 112 (2007) 568–576 573

















ig. 2. Immunohistochemical labeling of CYP1A1 in rats treated with WG a
ositive (arrow) is indicated in the hepatic section.
ine, treated with WG with or without BP (Fig. 3). Quantita-
ive RT-PCR showed that CYP1A1 mRNA was significantly
ncreased by BP treatment (1 M) for 12 h (Fig. 3A). Treat-
ent of the cells with WG (0.1–1 mg/ml) for 1 h following
P exposure blocked the increase in CYP1A1 mRNA by BP.
qual mRNA loading in the lanes was confirmed by GAPDH.
estern blot analysis revealed that BP treatment resulted in
he induction of CYP1A1. WG pretreatment caused 60% sup-
ig. 3. The effects of WG on BP-induced CYP1A1 expression: (A) the level
f CYP1A1 mRNA was assessed by RT-PCR. Cells were pretreated with WG
0.1–1 mg/ml) for 1 h, followed by BP treatment for 6 h. Results were confirmed
y repeated experiments. Values indicate the relative densitometric intensities
relative level in untreated control = 1) and (B) the level of CYP1A1 was assessed
y immunoblotting. Cells were treated with WG (0.1–1 mg/ml) in the presence
f BP for 12 h.
Fig. 4. The effects of WG on GST expression: (A) the levels of GSTA2/3/5 and
GSTM1/2 were assessed by RT-PCR. Cells were treated with WG (0.1, 1 mg/ml)
for 6 h. Results were confirmed by repeated experiments. Values indicate the
relative densitometric intensities (relative level in untreated control = 1) and (B)
the levels of GST and  were assessed by immunoblotting. Cells were treated
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ression of BP-induced CYP1A1 protein expression (Fig. 3B).
hese results were consistent with those of the RT-PCR
nalyses.
.7. Effect of WG on GST gene expression
Studies were extended to determine the effects of WG on
ST gene expression. The mRNA levels for the major GSTs
ere monitored in H4IIE cells (Fig. 4A). First, the mRNA lev-
ls were determined in cells treated with WG (0.1, 1 mg/ml).
G treatment caused significant induction in GSTA2, GSTA3
nd GSTM2 mRNA in a dose-dependent manner by two-, two-,
nd three-fold, respectively, compared to the control (Fig. 4A).
STM1 was moderately induced by WG, whereas GSTA5 was
ot changed.
To determine whether changes in the levels of the major GST
RNA paralleled those of GST subunits, western blot analysis
as also performed. The GST protein expression was four-
old induced by WG (1 mg/ml) relative to control (Fig. 4B).
he levels for GST subunits were ∼90% induced in WG-
reated (0.1 mg/ml) cells. Hence, the major GST subunits were
ignificantly induced by WG.
ig. 5. GSTA2 promoter luciferase reporter gene analyses: (A) the GSTA2
himeric gene constructs in the flanking insert and (B) induction of luciferase
ctivity by WG in H4IIE cells transiently transfected with GSTA2 chimeric
ene construct pGL-1651, which contains the ARE binding site of the GSTA2
romoter, or pGL-ARE, in which the ARE is deleted. H4IIE cells were
o-transfected with the GSTA2-luciferase gene construct pGL-1651 or ARE-
eleted pGL-1651 (firefly luciferase) and pRL-SV (Renilla luciferase) at a ratio
f 200:1 and subsequently treated with WG (1 mg/ml) for 12 h; lysates from these
ells were used for dual luciferase reporter assays. Activation of the reporter gene
as calculated as a change in the ratio of firefly luciferase activity to Renilla
uciferase activity (control level = 1). One-way analysis of variance was used
or comparisons of means of multiple groups followed by Newman–Keuls test
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.8. Analysis of the ARE in the GSTA2 promoter
A previous study showed that activation of ARE is involved in
he induction of GSTA2 expression (Kang et al., 2003). Given
he role of ARE in GSTA2 expression, we examined whether
G might transcriptionally activate GSTA2 expression via the
RE binding site. Reporter gene assays were therefore per-
ormed using H4IIE cells transfected with the mammalian cell
xpression vector pGL-1651, which contained the luciferase
tructural gene downstream of the −1.65 kb GSTA2 promoter
egion (Fig. 5). Exposure of transiently transfected cells to WG
esulted in a three-fold increase in luciferase activity. No WG-
ediated luciferase activity was induced in cells transfected with
he pGL-ARE gene construct, which lacks the ARE. Pro-
oter deletion experiments demonstrated that the location of
he GSTA2 regulatory region that confers WG responsiveness
ncluded the ARE binding site.
. Discussion
Panax ginseng C.A. Meyer (Araliaceae) is a valuable herb in
ast Asia that has also gained popularity in the West because
f its pharmacological properties (Zhang et al., 1996). Ginseno-
ides, such as Rg3, Rg5 and Rh2, are active anti-carcinogenic
omponents in red ginseng, and they prevent cancer either
ingularly or synergistically (Yun et al., 2001b). White gin-
eng may have inhibitory effects on the progression stage
f rat intestinal carcinogenesis (Ichihara et al., 2002). In the
resent study, wild ginseng, which grows naturally in Sobaek-
an, potently prevented the BP-induced hepatotoxicity in rats,
s assessed by blood biochemical and histopathological analy-
es. BP is an effective carcinogen that interacts with membrane
ipids and, consequently, induces free radical formation (Garcon
t al., 2001). Free radicals react further with lipids causing
eroxidation, resulting in the release of products such as malon-
ialdehyde, hydroperoxides and hydroxyl radicals. Free radicals
lso participate in carcinogenesis as measured by BP-induced
epatic 8-hydroxyguanine production (Urios and Blanco, 1996;
arcon et al., 2001). Our results demonstrate that WG also
educed BP-induced lipid peroxidation, which may in turn block
ormation of free radical-mediated DNA adducts.
GSH, a substrate for GST, plays an important role in
etoxifying reactive metabolites of electrophilic carcinogens.
P resulted in decrease of the hepatic glutathione content,
hich would enhance oxidative stress and stimulate serious
amage to hepatocytes. Srivastava et al. (2000) reported that
,l-buthionine-S,R-sulfoximine (BSO)-mediated tissue GSH
epletion caused an increase in BP-induced tumor multiplic-
ty. As shown in Table 2, WG reversed BP-mediated GSH
ecreases to the control level in hepatic tissues. In addition,
P decreased GST activity, which catalyzes GSH conjugation
ith BP metabolites. However, WG pretreatment returned GST
ctivity to control levels. The effects of WG on GSH/GST lev-
ls suggest that it offers potential protection against carcinogenic
isks associated with BP.
The hepatotoxic potential of BP not only varies between
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nd the antioxidant defense system (Alexandrov et al., 2002).
YP1A1 and GSTM1 genotypes are critical determinants of
P DNA adduct formation (Alexandrov et al., 2002). Thus, this
rotective effect of WG may be associated with metabolic regu-
ation of BP. In general, CYP450-related enzymes activate BP by
roducing highly mutagenic DNA-damaging metabolites called
PDE (Melendez-Colon et al., 1999). Elevated CYP1A1 activ-
ty correlates with BPDE-associated DNA adduction, one of the
rst critical events in tumor initiation (Rojas et al., 1992). This
tudy showed that WG inhibited BP-induced CYP1A1 expres-
ion in both rats and H4IIE cells. It appears likely that the
nhibitory effects of WG may partly prevent the BP-induced
umor initiation and DNA binding.
GST enzymes are involved in the metabolism of a wide vari-
ty of electrophilic carcinogens (Alexandrov et al., 2002; Singh
t al., 2004). The GSTs are a family of enzymes that assist in the
xcretion of carcinogens by making them soluble via conjuga-
ion with GSH (Hesse et al., 1980; Sundberg et al., 2002). Thus,
he GSTs are used as a biomarker to investigate the chemo-
reventive effects of agents (Manson et al., 1997). GSTA1-1
onjugates metabolites derived from dibenzo[]pyrene very effi-
iently (Sundberg et al., 2002). Moreover, the GST M1 null
enotype in humans has also been shown to be a risk factor in
P-induced cancer (Alexandrov et al., 2002). This study showed
hat WG may hinder carcinogenesis by aiding the excretion of
lectrophilic carcinogens in the early stage of cancer develop-
ent, via inducing GSH and GST /. Here, we found for the
rst time that WG significantly increases GSTA2, GSTA3 and
STM2 mRNA and moderately increases GST M1 mRNA.
hese mRNA increases are consistent with protein expres-
ion as well. These results suggest that WG-mediated increases
n GST detoxify metabolites of BP by conjugating them
ith GSH.
Nrf2-deficient mice exhibit increased sensitivity to carcino-
ens, which supports the concept that Nrf2-mediated gene
ranscription is essential for the prevention of chemical car-
inogenesis by chemoprotective agents. Here, we reported that
G increased GST promoter activity, but failed to increase this
ctivity when the ARE binding site was deleted from the pro-
oter. These results provide evidence that Nrf2 transactivation
s functionally involved in WG-mediated increases in GSTA2
xpression.
Taken together, the above results suggest that WG inhibits
P-induced hepatotoxicity and modulates the metabolizing
nzymes, reducing the P450-mediated metabolic activation and
nhancing detoxification through induction of phase II enzymes.
hus, WG appears to have the potential to defend against BP-
nduced carcinogenic risk.
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